| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 1.044 | 10.102 | 12.785 | 19.954 | 20.616 | 15.007 | 10.275 | 8.678 |
| Total Income - EUR | - | - | 1.044 | 10.102 | 12.785 | 19.954 | 36.082 | 15.098 | 10.313 | 9.792 |
| Total Expenses - EUR | - | - | 991 | 3.985 | 8.101 | 11.634 | 29.851 | 18.805 | 15.735 | 14.656 |
| Gross Profit/Loss - EUR | - | - | 53 | 6.116 | 4.684 | 8.320 | 6.230 | -3.707 | -5.422 | -4.863 |
| Net Profit/Loss - EUR | - | - | 21 | 5.813 | 4.300 | 7.762 | 5.170 | -4.160 | -5.422 | -5.157 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Lira Newmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 63 | 62 | 17.954 | 13.480 | 41.042 | 33.468 | 26.280 | 19.975 |
| Current Assets | - | - | 409 | 5.933 | 3.897 | 13.949 | 6.393 | 4.293 | 2.884 | 848 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 399 | 3.512 | 316 | 3.069 | 16 | 292 | 38 | 130 |
| Cash | - | - | 11 | 2.421 | 3.581 | 10.880 | 6.377 | 4.001 | 2.846 | 717 |
| Shareholders Funds | - | - | 65 | 5.877 | 10.064 | 17.635 | 22.414 | 18.324 | 12.847 | 7.618 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 407 | 117 | 11.787 | 9.794 | 25.021 | 19.438 | 16.317 | 13.204 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Lira Newmed Srl